| ABCA1 | ATP-binding cassette transporter A1 |
| ABCG1 | ATP-binding cassette transporter G1 |
| AGEs | Advanced glycation end products |
| ApoA1 | Apolipoprotein A-I |
| ApoB | Apolipoprotein B |
| ApoC-III | Apolipoprotein C-III |
| ApoE | Apolipoprotein E |
| ASCVD | Atherosclerotic Cardiovascular Disease |
| CAD | Coronary Artery Disease |
| CE | Cholesteryl Esters |
| CEC | Cholesterol efflux capacity |
| CETP | Cholesteryl Ester Transfer Protein |
| CVD | Cardiovascular Disease |
| DHCR24 | 3-β-Hydroxysteroid-Δ24 reductase |
| dHDL | Dysfunctional high-density lipoprotein |
| eNOS | Endothelial nitric oxide synthase |
| HDL | High-Density Lipoprotein |
| HDL-C | High-density lipoprotein cholesterol |
| IL-6 | Interleukin-6 |
| LCAT | Lecithin Cholesterol Acyltransferase |
| LDL | Low-Density Lipoprotein |
| LDL-C | Low-density lipoprotein cholesterol |
| MACE | Major adverse cardiovascular events |
| MDA | Malondialdehyde |
| NLRP3 | NOD-, LRR- and Pyrin Domain-containing Protein 3 |
| NO | Nitric oxide |
| oxLDL | Oxidized Low-Density Lipoprotein |
| PAF-AH | Platelet-activating factor acetylhydrolase |
| PAD | Peripheral Artery Disease |
| PI3K | Phosphatidylinositol 3-kinase |
| PLTP | Phospholipid Transfer Protein |
| PON1 | Paraoxonase 1 |
| PTMs | Posttranslational Modifications |
| RCT | Reverse Cholesterol Transport |
| ROS | Reactive Oxygen Species |
| SAA | Serum Amyloid A |
| SDMA | Symmetric Dimethylarginine |
| S1P | Sphingosine-1-Phosphate |
| SR-BI | Scavenger receptor class B type I |
| T2DM | Type 2 Diabetes Mellitus |
| TG | Triglyceride |
| TLR2 | Toll-like Receptor 2 |
| TNF-α | Tumor Necrosis Factor-α |
| WWP2 | WW Domain Containing E3 Ubiquitin Protein Ligase 2 |